597 related articles for article (PubMed ID: 15699376)
21. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
22. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
Natarajan S; Jabbour JT; Webster CJ; Richardson MS
Headache; 2004; 44(10):969-77. PubMed ID: 15546259
[TBL] [Abstract][Full Text] [Related]
23. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
24. Randomized evaluation of octreotide vs prochlorperazine for ED treatment of migraine headache.
Miller MA; Levsky ME; Enslow W; Rosin A
Am J Emerg Med; 2009 Feb; 27(2):160-4. PubMed ID: 19371522
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
26. Midazolam vs. diphenhydramine for the treatment of metoclopramide-induced akathisia: a randomized controlled trial.
Parlak I; Erdur B; Parlak M; Ergin A; Ayrik C; Tomruk O; Turkcuer I; Ergin N
Acad Emerg Med; 2007 Aug; 14(8):715-21. PubMed ID: 17545174
[TBL] [Abstract][Full Text] [Related]
27. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.
Goldstein J; Silberstein SD; Saper JR; Elkind AH; Smith TR; Gallagher RM; Battikha JP; Hoffman H; Baggish J
Headache; 2005 Sep; 45(8):973-82. PubMed ID: 16109110
[TBL] [Abstract][Full Text] [Related]
28. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
29. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
[TBL] [Abstract][Full Text] [Related]
30. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
31. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department.
Cete Y; Dora B; Ertan C; Ozdemir C; Oktay C
Cephalalgia; 2005 Mar; 25(3):199-204. PubMed ID: 15689195
[TBL] [Abstract][Full Text] [Related]
32. [Subcutaneous sumatriptan in the treatment of migraine attacks. An analysis of its long term efficaciousness and tolerance].
Leira R; Suárez C; Castillo J; Lema M; Noya M
Rev Neurol; 1995; 23(122):752-5. PubMed ID: 7497233
[TBL] [Abstract][Full Text] [Related]
33. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.
Jakubowski M; Levy D; Goor-Aryeh I; Collins B; Bajwa Z; Burstein R
Headache; 2005; 45(7):850-61. PubMed ID: 15985101
[TBL] [Abstract][Full Text] [Related]
34. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences.
Cohen JA; Beall DG; Miller DW; Beck A; Pait G; Clements BD
Fam Med; 1996 Mar; 28(3):171-7. PubMed ID: 8900548
[TBL] [Abstract][Full Text] [Related]
35. A Randomized Controlled Trial of Intravenous Haloperidol vs. Intravenous Metoclopramide for Acute Migraine Therapy in the Emergency Department.
Gaffigan ME; Bruner DI; Wason C; Pritchard A; Frumkin K
J Emerg Med; 2015 Sep; 49(3):326-34. PubMed ID: 26048068
[TBL] [Abstract][Full Text] [Related]
36. Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache.
Griffith JD; Mycyk MB; Kyriacou DN
J Pain; 2008 Jan; 9(1):88-94. PubMed ID: 17981511
[TBL] [Abstract][Full Text] [Related]
37. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
38. Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?
Calhoun AH; Ford S
Postgrad Med; 2014 Mar; 126(2):86-90. PubMed ID: 24685971
[TBL] [Abstract][Full Text] [Related]
39. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
Silberstein SD; Mannix LK; Goldstein J; Couch JR; Byrd SC; Ames MH; McDonald SA; Lener SE; Toso C
Neurology; 2008 Jul; 71(2):114-21. PubMed ID: 18606965
[TBL] [Abstract][Full Text] [Related]
40. Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications.
Kelley NE; Tepper DE
Headache; 2012 Mar; 52(3):467-82. PubMed ID: 22404708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
